First-time-in-Human (FTIH) Study to Evaluate Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of Single (in Both Fed and Fasted States) or Repeat Doses of GSK3358699
Clinical trial NCT03426995 · TERMINATED
Trial details
- NCT number
- NCT03426995
- Sponsor
- GlaxoSmithKline
- Status
- TERMINATED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2018-03-13
- Primary completion
- 2019-05-02
- Enrollment
- 48
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.